Filter by date
- November 2022 (3)
- October 2022 (1)
- August 2022 (1)
- July 2022 (1)
- June 2022 (1)
- April 2022 (4)
- March 2022 (3)
- December 2021 (2)
- November 2021 (1)
- October 2021 (1)
- July 2021 (1)
- May 2021 (2)
- April 2021 (1)
- January 2021 (1)
- May 2020 (1)
- December 2019 (1)
- September 2019 (10)
- June 2019 (1)
- March 2019 (2)
- January 2019 (7)
- November 2018 (1)
- September 2018 (2)
- July 2018 (2)
- May 2018 (2)
- April 2018 (1)
- February 2018 (1)
- November 2017 (1)
- September 2017 (1)
- August 2017 (1)
- January 2017 (3)
- November 2016 (1)
- October 2016 (18)
- September 2016 (1)
- July 2016 (1)
- March 2016 (1)
- February 2016 (1)
- December 2015 (2)
- November 2015 (1)
- September 2015 (1)
- March 2015 (1)
- February 2015 (1)
May 14, 2021
AI-Powered Cardiac Monitoring with iRhythm's Michael Coyle and Dr. Mark Day
April 16, 2021
Putting Patient Care and Heart Health Innovation First: Medicare Reimbursement for Long-Term Continuous ECG Technology
January 28, 2021
New iRhythm CEO on national pricing setback, Medtronic market expansion lessons
May 26, 2020
UCSF studies how coronavirus attacks the human heart
December 31, 2020
iRhythm Technologies to Present at the 38th Annual J.P. Morgan Healthcare Conference
September 11, 2019
iRhythm Technologies Teams With Verily for Early Detection of AFib
September 9, 2019
Verily And iRhythm Agree To Collaborate On Atrial Fibrillation
September 6, 2019
Verily and iRhythm join forces to detect silent atrial fibrillation
September 6, 2019
iRhythm Technologies to work with Verily to address challenge of identifying patients with undiagnosed atrial fibrillation
September 5, 2019
iRhythm unveils $13m Verily afib deal, readies $100m offering